根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$IsoRay(ISR)$ CT ORDER - Confidential treatment order Filed: 2017-02-08 AccNo: 9999999997-17-000606 Size: 13 KB 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2017-02-08 AccNo: 0001144204-17-006754 Size: 101 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2017-02-06 AccNo: 0001144204-17-006214 Size: 16 KBItem 8.01: Other Events 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2017-02-03 AccNo: 0001144204-17-005924 Size: 31 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay(ISR)$ 8-K/A [Amend] - Current report Filed: 2017-01-23 AccNo: 0001144204-17-003424 Size: 13 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2017-01-17 AccNo: 0001144204-17-002308 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$IsoRay(ISR)$ 内部交易: 2017-01-04,Director,Vitale Philip J ,买入,20000普通股, $0.66
$IsoRay(ISR)$ 8-K - Current report Filed: 2016-12-28 AccNo: 0001144204-16-141569 Size: 25 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay(ISR)$ 8-K - Current report Filed: 2016-12-20 AccNo: 0001144204-16-140509 Size: 22 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$IsoRay(ISR)$ 内部交易: 2016-12-08,Director,Hoffmann Alan ,买入,20000普通股, $0.57